Takao Takeshima
Osaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 103 publications
Diagnostic Reclassification From Parkinson's Disease to Multiple System Atrophy Based on Longitudinal Clinical and Imaging Findings: A Case Report.
Journal: Cureus
Published: June 06, 2026
Use of CGRP Monoclonal Antibodies in Japan, South Korea, and Taiwan: A Narrative Review.
Journal: Current pain and headache reports
Published: January 26, 2026
Clinical characteristics, neurovascular compression, and treatment outcomes in SUNCT and SUNA: A contemporary Japanese consecutive case series.
Journal: Headache
Published: January 11, 2026
Effectiveness of Galcanezumab and Traditional Oral Migraine Preventive Medications: Interim 3-Month Japan Subgroup Findings from the TRIUMPH Study.
Journal: Advances in therapy
Published: December 29, 2025
Atogepant for the Preventive Treatment of Migraine in Japanese Participants: A Phase 3, Open-Label, 52-Week Extension Study.
Journal: Neurology and therapy
Published: December 23, 2025
Delphi consensus on the real-world application of the updated diagnostic and treatment guidelines for migraine in Asia Pacific.
Journal: Frontiers in neurology
Published: December 18, 2025
Long-term safety and effectiveness of rimegepant for the preventive treatment of migraine in Japan: an open-label extension of a phase 3 study.
Journal: The journal of headache and pain
Published: December 17, 2025
Last Updated: 09/26/2026